Latest database descriptions

Percentage of patients positive for Covid-19

Study the coagulopathy, vascular lesion and markers for tissue distress to characterise the exacerbation of patients with COVID-19 and identify patient populations who will develop or experience exacerbation of a thromboembolic or microvascular process, but also require curative anticoagulation.

The primary objective is to demonstrate the reliability and safety of outpatient management among patients highly suspected or confirmed as infected with COVID-19, attending an emergency department and with a revised HOME-CoV score less than 2 (negative rule).

The secondary objectives are as follows:
i. Evaluate the rate of patients having required hospitalisation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
ii. Evaluate the rate of patients having required hospitalisation and initiation of oxygen therapy within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
iii. Evaluate the rate of patients having required intubation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
iv. Evaluate the rate of all-cause deaths within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
v. Evaluate the performance of the revised HOME-CoV score in predicting a
negative outcome in the patient subgroup with SARS-CoV-2 infection
confirmed by RT-PCR to rule out the risk of a negative outcome when assessed as low risk.
vi. Compare the performance of the revised HOME-CoV score with that of other existing scores.

Compare the rate of patients forgoing care during the lockdown period in France, in emergency facilities at Angers and Le Mans hospitals, with that observed during a previous study in 2017.